Literature DB >> 19217256

Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement.

Julian Little1, Julian P T Higgins, John P A Ioannidis, David Moher, France Gagnon, Erik von Elm, Muin J Khoury, Barbara Cohen, George Davey-Smith, Jeremy Grimshaw, Paul Scheet, Marta Gwinn, Robin E Williamson, Guang Yong Zou, Kim Hutchings, Candice Y Johnson, Valerie Tait, Miriam Wiens, Jean Golding, Cornelia van Duijn, John McLaughlin, Andrew Paterson, George Wells, Isabel Fortier, Matthew Freedman, Maja Zecevic, Richard King, Claire Infante-Rivard, Alex F Stewart, Nick Birkett.   

Abstract

Making sense of rapidly evolving evidence on genetic associations is crucial to making genuine advances in human genomics and the eventual integration of this information in the practice of medicine and public health. Assessment of the strengths and weaknesses of this evidence, and hence, the ability to synthesize it, has been limited by inadequate reporting of results. The STrengthening the REporting of Genetic Association (STREGA) studies initiative builds on the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement and provides additions to 12 of the 22 items on the STROBE checklist. The additions concern population stratification, genotyping errors, modeling haplotype variation, Hardy-Weinberg equilibrium, replication, selection of participants, rationale for choice of genes and variants, treatment effects in studying quantitative traits, statistical methods, relatedness, reporting of descriptive and outcome data, and the volume of data issues that are important to consider in genetic association studies. The STREGA recommendations do not prescribe or dictate how a genetic association study should be designed, but seek to enhance the transparency of its reporting, regardless of choices made during design, conduct, or analysis.

Entities:  

Mesh:

Year:  2009        PMID: 19217256     DOI: 10.1016/j.jclinepi.2008.12.004

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  40 in total

1.  STrengthening the reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Authors:  Valentina Gallo; Matthias Egger; Valerie McCormack; Peter B Farmer; John P A Ioannidis; Micheline Kirsch-Volders; Giuseppe Matullo; David H Phillips; Bernadette Schoket; Ulf Stromberg; Roel Vermeulen; Christopher Wild; Miquel Porta; Paolo Vineis
Journal:  Eur J Epidemiol       Date:  2011-10-29       Impact factor: 8.082

2.  Reporting guidelines and the American Journal of Public Health's adoption of Preferred Reporting Items for Systematic reviews and Meta-Analyses.

Authors:  Kenneth R McLeroy; Mary E Northridge; Hector Balcazar; Michael R Greenberg; Stewart J Landers
Journal:  Am J Public Health       Date:  2012-03-15       Impact factor: 9.308

Review 3.  Research review: gene-environment interaction research in youth depression - a systematic review with recommendations for future research.

Authors:  Erin C Dunn; Monica Uddin; S V Subramanian; Jordan W Smoller; Sandro Galea; Karestan C Koenen
Journal:  J Child Psychol Psychiatry       Date:  2011-09-29       Impact factor: 8.982

4.  Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans.

Authors:  Paolo Boffetta; Deborah M Winn; John P Ioannidis; Duncan C Thomas; Julian Little; George Davey Smith; Vincent J Cogliano; Stephen S Hecht; Daniela Seminara; Paolo Vineis; Muin J Khoury
Journal:  Int J Epidemiol       Date:  2012-05-16       Impact factor: 7.196

5.  LH (Trp8Arg/Ile15Thr), LHR (insLQ) and FSHR (Asn680Ser) polymorphisms genotypic prevalence in women with endometriosis and infertility.

Authors:  Carla Regina Schmitz; Carlos Augusto Bastos de Souza; Vanessa Krebs Genro; Ursula Matte; Emily de Conto; João Sabino Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2015-05-03       Impact factor: 3.412

6.  Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with myocardial infarction in a Latvian population.

Authors:  Vita Ignatovica; Gustavs Latkovskis; Raitis Peculis; Kaspars Megnis; Helgi B Schioth; Iveta Vaivade; Davids Fridmanis; Valdis Pirags; Andrejs Erglis; Janis Klovins
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

7.  External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails.

Authors:  Johannes Schetelig; Henning Baldauf; Falk Heidenreich; Carolin Massalski; Sandra Frank; Jürgen Sauter; Matthias Stelljes; Francis Ayuketang Ayuk; Wolfgang A Bethge; Gesine Bug; Stefan Klein; Sarah Wendler; Vinzenz Lange; Liesbeth C de Wreede; Daniel Fürst; Guido Kobbe; Hellmut D Ottinger; Dietrich W Beelen; Joannis Mytilineos; Katharina Fleischhauer; Alexander H Schmidt; Martin Bornhäuser
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

8.  The role of common and rare MC4R variants and FTO polymorphisms in extreme form of obesity.

Authors:  Vita Rovite; Ramona Petrovska; Iveta Vaivade; Ineta Kalnina; Davids Fridmanis; Linda Zaharenko; Raitis Peculis; Valdis Pirags; Helgi B Schioth; Janis Klovins
Journal:  Mol Biol Rep       Date:  2014-01-03       Impact factor: 2.316

9.  Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.

Authors:  Yvonne N Flores; Rafael Velázquez-Cruz; Paula Ramírez; Manuel Bañuelos; Zuo-Feng Zhang; Hal F Yee; Shen-Chih Chang; Samuel Canizales-Quinteros; Manuel Quiterio; Guillermo Cabrera-Alvarez; Nelly Patiño; Jorge Salmerón
Journal:  Mol Biol Rep       Date:  2016-10-17       Impact factor: 2.316

10.  The effect of 5-fluorouracil/leucovorin chemotherapy on CpG methylation, or the confounding role of leukocyte heterogeneity: An illustration.

Authors:  Mathieu Lemire; Syed H E Zaidi; Brent W Zanke; Steven Gallinger; Thomas J Hudson; Sean P Cleary
Journal:  Genomics       Date:  2015-09-11       Impact factor: 5.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.